by | May 12, 2026 | Cui, Jianmin
— Published date: 5/13/2026
Value Proposition: Non-invasive stimulation strategy that can deliver dynamic glycemic control to treat Type 1 diabetes.
Technology Description
Researchers at Washington University in St. Louis have developed Acoustic-Controlled Insulin Secretion (ACIS), a novel sono…
by | May 12, 2026 | Chen, Hong, Cui, Jianmin
— Published date: 5/13/2026
Value Proposition: Non-invasive stimulation strategy that can deliver dynamic glycemic control to treat Type 1 diabetes.
Technology Description
Researchers at Washington University in St. Louis have developed Acoustic-Controlled Insulin Secretion (ACIS), a novel sono…
by | Jun 3, 2025 | Feldman, Mario, Jana, Biswanath, Pardue, Evan, Sartorio, Mariana
— Published Date: 6/3/2025
Value Proposition: System that employs gut microbe strains engineered with therapeutic enzymes to treat chronic gut conditions.
Technology Description
Researchers at Washington University in St. Louis have developed a hypervesiculating Bacteroides theatiotaomicron (Bt) …
by | May 13, 2025 | Haller, Gabriel, Li, Chengcheng, Weihl, Conrad
— Published Date: 5/14/2025
Value Proposition: Method that uses gene-therapy to detect limb-girdle muscular dystrophy (LGMD) type 4R/2E.
Technology Description
Researchers at Washington University in St. Louis have developed a method of predicting limb-girdle muscular dystrophy (LGMD) type 4R/2…
by | Feb 23, 2022 | Cui, Jianmin
— Disease indication – Long QT Syndrome (resulting in ventricular arrhythmia, epilepsy, deafness)
Drug format – Small molecule
Drug class – Lead compounds are repurposed drugs
Research stage and preliminary data – Based on in silico screening of KCNQ, the researchers selecte…